• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Expert Rev Vaccines . Evaluation of influenza vaccination efficacy in reducing influenza-related complications and excess mortality in Northern Ital

tetano

Editor, Senior Moderator
Expert Rev Vaccines


. 2021 Jan 22;1-9.
doi: 10.1080/14760584.2021.1874927. Online ahead of print.
Evaluation of influenza vaccination efficacy in reducing influenza-related complications and excess mortality in Northern Italy (2014-2017)


Giuseppe Marano[SUP] 1 [/SUP], Patrizia Boracchi[SUP] 1 [/SUP], Ester Luconi[SUP] 2 [/SUP], Elena Pariani[SUP] 3 [/SUP], Laura Pellegrinelli[SUP] 3 [/SUP], Cristina Galli[SUP] 3 [/SUP], Cecilia E Gandolfi[SUP] 3 [/SUP], Michele Magoni[SUP] 4 [/SUP], Antonio Piro[SUP] 4 [/SUP], Carmelo Scarcella[SUP] 4 [/SUP], Silvana Castaldi[SUP] 2 3 [/SUP], Elia M Biganzoli[SUP] 1 [/SUP]



Affiliations

Abstract

Objective: The main objective of this study was to estimate the efficacy of influenza vaccination in reducing influenza-attributable hospitalization and emergency room (ER) admission for severe complications and influenza-attributable excess mortality in individuals ≥65 years of age.
Methods: We analyzed the ≥65 years-old community (n = 952,822) afferent to the Brescia (Northern Italy) Health Protection Agency, considered an Italian population reference, to evaluate the efficacy of influenza vaccination (seasons 2014-17) in reducing deaths, ER-admissions, and hospitalizations for influenza-related complications in the elderly.
Results: A protective effect of influenza vaccination emerged in reducing hospitalization and ER admission for diseases of the respiratory system and for death from all causes in people ≥65 years. The major effect of influenza vaccination was the reduction in risk of death from all causes, increasing with age and comorbidity.
Conclusion: Influenza vaccination has reduced the number of ER admissions and hospitalizations caused by influenza-related complications and has prevented death among high-risk groups in elderly ≥65 years, resulting in social and public health cost savings. Stronger or new vaccination strategies are needed to improve vaccination rates among the elderly.

Keywords: Efficacy of influenza vaccination; cardiac disease and stroke; death from all causes; diseases of the respiratory system; elderly.
 
Back
Top Bottom